Researchers from the University of California, Irvine developed a deep learning-based approach to accelerate drug discovery and cancer research.

“We have developed a convolutional neural network to improve the data analysis processes for high-throughput drug screening using our microphysiological system (MPS),” the researchers stated in their paper.